department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Olmesartan Medoxomil · pharmadog

pharmadog
drugs
Olmesartan Medoxomil

drug

patient view →

olmesartan medoxomil

Marketedupdated 2mo ago

by Umedica Laboratories Pvt Ltd

Approved

community read0 votes

indications

investigational

Hypertension

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Olmesartan Medoxomil

generic

olmesartan medoxomil

indication

Hypertension

phase

marketed

Data sources

ClinicalTrials.gov

last refreshed 54m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval26 co-mentions · 13 sources
drugALDACTAZIDE24 co-mentions · 13 sources
tagSmall Molecule13 co-mentions · 13 sources
drugOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE11 co-mentions · 11 sources
drugamlodipine5 co-mentions · 3 sources
drugOLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE4 co-mentions · 2 sources
companyAurobindo Pharma Ltd3 co-mentions · 3 sources
drugamlodipine besylate2 co-mentions · 2 sources

Trials studying olmesartan medoxomil

phase3Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Controlwithdrawn
phase3Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Controlwithdrawn
—Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tabactive not recruitingn=2,845
—Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemiaactive not recruitingn=4,000
—Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tabcompletedn=5,450
phase1Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgcompletedn=36
phase1Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mgcompletedn=36
phase1Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mgcompletedn=36

more trials →